{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:31:00Z","timestamp":1790310660776,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.dld.2008.11.020","type":"journal-article","created":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T03:40:41Z","timestamp":1234410041000},"page":"570-577","source":"Crossref","is-referenced-by-count":71,"title":["Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: Clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan"],"prefix":"10.1016","volume":"41","author":[{"given":"T.","family":"Hibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Sameshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Hisatome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Moriwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Saniabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2008.11.020_bib1","series-title":"Inflammatory bowel disease","first-page":"9","year":"1998"},{"key":"10.1016\/j.dld.2008.11.020_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2008.11.020_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00004836-199506000-00004","article-title":"How effective is current medical therapy for severe ulcerative colitis?","volume":"20","author":"Kornbluth","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2008.11.020_bib4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/BF01296907","article-title":"Sulphasalazine\u2014adverse effects and desensitization","volume":"28","author":"Taffet","year":"1983","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.11.020_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ibd.3780060110","article-title":"How to do without steroids in inflammatory bowel disease","volume":"6","author":"Present","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.11.020_bib6","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2004.02.071","article-title":"Medical therapy of ulcerative colitis","volume":"126","author":"Hanauer","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.11.020_bib7","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(74)90552-2","article-title":"Intensive intravenous regimens for severe attacks of ulcerative colitis","volume":"1","author":"Truelove","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.11.020_bib8","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0016-5085(85)90201-X","article-title":"Intensive intravenous treatment of ulcerative colitis","volume":"89","author":"Jarnerot","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.11.020_bib9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/gast.2001.23983","article-title":"Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis","volume":"120","author":"D\u2019Haens","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.11.020_bib10","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"10.1016\/j.dld.2008.11.020_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2036.16.s4.8.x","article-title":"Review article: a critical approach to new forms of treatment of Crohn's disease and ulcerative colitis","volume":"16","author":"Seegers","year":"2002","journal-title":"Alimnt Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.11.020_bib12","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","article-title":"Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration","volume":"46","author":"Brown","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.dld.2008.11.020_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","article-title":"Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes","volume":"7","author":"Saniabadi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.dld.2008.11.020_bib14","first-page":"295","article-title":"The role of peripheral lymphocytes in the prediction of recurrence in Crohn's disease","volume":"160","author":"Heimann","year":"1985","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.dld.2008.11.020_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/B:DDAS.0000026299.43792.ae","article-title":"Selective neutrophil and monocyte adsorptive apheresis as a first line treatment for steroid na\u00efve patients with active ulcerative colitis: a prospective uncontrolled study","volume":"49","author":"Suzuki","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.11.020_bib16","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s10620-006-9406-8","article-title":"Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: clinical efficacy, effects on plasma IL-8 and the expression of toll like receptor 2 on granulocytes","volume":"52","author":"Aoki","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.11.020_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2249.1991.tb02958.x","article-title":"Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease","volume":"86","author":"McCarthy","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2008.11.020_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00024382-200005000-00003","article-title":"Neutrophil apoptosis is delayed in patients with inflammatory bowel disease","volume":"13","author":"Brannigan","year":"2000","journal-title":"Shock"},{"key":"10.1016\/j.dld.2008.11.020_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jlb.54.4.283","article-title":"Inhibition of apoptosis and prolongation of\u00a0neutrophil functional longevity by inflammatory mediators","volume":"54","author":"Lee","year":"1993","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.dld.2008.11.020_bib20","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.4049\/jimmunol.156.11.4422","article-title":"Opposing effects of glucocorticoids on the rate of appoptosis in neutrophilic and eosinophilic granulocytes","volume":"156","author":"Meagher","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.dld.2008.11.020_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2000.8523","article-title":"Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease","volume":"119","author":"Tibble","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.11.020_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(98)03339-X","article-title":"Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease","volume":"353","author":"Schreiber","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.11.020_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.med.51.1.289","article-title":"Role of cytokines in the pathogenesis of inflammatory bowel disease","volume":"51","author":"Papadakis","year":"2000","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.dld.2008.11.020_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0167-5699(95)80066-2","article-title":"The production of cytokines by polymorphonuclear neutrophils","volume":"16","author":"Cassatella","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.dld.2008.11.020_bib25","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/gut.42.4.470","article-title":"Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin-10 during intestinal inflammation","volume":"42","author":"Nikolaus","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.11.020_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nm0107-26","article-title":"IL-23: a master regulator in Crohn's disease","volume":"13","author":"Neurath","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.dld.2008.11.020_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.20046","article-title":"Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?","volume":"20","author":"Saniabadi","year":"2005","journal-title":"J Clin Apher"},{"key":"10.1016\/j.dld.2008.11.020_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.transci.2007.08.003","article-title":"Therapeutic leucocytapheresis for inflammatory bowel disease","volume":"37","author":"Saniabadi","year":"2007","journal-title":"Transf Aphere Sci"},{"key":"10.1016\/j.dld.2008.11.020_bib29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.dld.2004.08.004","article-title":"Evaluation of granulocyte\/monocyte apheresis therapy for active ulcerative colitis","volume":"36","author":"Kanke","year":"2004","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.dld.2008.11.020_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","article-title":"Safety and efficacy of granulocyte and monocyte apheresis in patients with active ulcerative colitis: a multicenter study","volume":"16","author":"Shimoyama","year":"2001","journal-title":"J Clin Aphere"},{"key":"10.1016\/j.dld.2008.11.020_bib31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/jcgh.2003.50005","article-title":"Leukcocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective uncontrolled pilot study","volume":"1","author":"Hanai","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.11.020_bib32","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.3748\/wjg.v12.i21.3393","article-title":"Effects of Adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with ulcerative colitis","volume":"12","author":"Hanai","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2008.11.020_bib33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00054725-200608000-00008","article-title":"Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: Cytokine profiles and endoscopic findings","volume":"12","author":"Yamamoto","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.11.020_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.1995.tb03620.x","article-title":"Human neutrophil Fc receptor mediated adhesion under flow: a hallow fiber model of intravascular arrest","volume":"100","author":"D\u2019Arrigo","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2008.11.020_bib35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1526-0968.2003.00049.x","article-title":"Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis","volume":"7","author":"Hiraishi","year":"2003","journal-title":"Ther Aphere Dial"},{"key":"10.1016\/j.dld.2008.11.020_bib36","unstructured":"Munakata A. A new criteria for diagnosis of ulcerative colitis. Annual Report of the Research Committee of Inflammatory Bowel Disease, the Ministry of Health and Welfare of Japan; 1998. p. 96\u20139."},{"key":"10.1016\/j.dld.2008.11.020_bib37","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in the treatment of ulcerative colitis: final report on a therapeutic trial","volume":"2","author":"Truelove","year":"1955","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2008.11.020_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","article-title":"Coated mesalazine (5-aminisalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial","volume":"298","author":"Rachmilewitz","year":"1989","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2008.11.020_bib39","first-page":"393","article-title":"The value of rectal biopsy in the diagnosis of ulcerative colitis","volume":"30","author":"Matts","year":"1961","journal-title":"Q J Med"},{"key":"10.1016\/j.dld.2008.11.020_bib40","first-page":"117","article-title":"Granulocyte and monocyte apheresis in the treatment of active ulcerative colitis","volume":"18","author":"Shimoyama","year":"1999","journal-title":"Jpn J Aphere"},{"key":"10.1016\/j.dld.2008.11.020_bib41","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00535-004-1465-z","article-title":"Granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study","volume":"39","author":"Fukuda","year":"2004","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2008.11.020_bib42","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1365-2036.2000.00802.x","article-title":"Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease","volume":"14","author":"Ang","year":"2000","journal-title":"Alimnt Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.11.020_bib43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/gast.2000.18159","article-title":"Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis","volume":"119","author":"Pan\u00e9s","year":"2000","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1016\/j.dld.2008.11.020_bib44","first-page":"53","article-title":"BioSense- a national initiative for early detection and quantification of public health emergencies","volume":"53","author":"Loonsk","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.dld.2008.11.020_bib45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/rheumatology\/keg263","article-title":"Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy","volume":"42","author":"Kroesen","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.dld.2008.11.020_bib46","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.dld.2008.11.020_bib47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000069965","article-title":"Adverse skin reactions to anti-TNF-\u03b1","volume":"206","author":"Devos","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.dld.2008.11.020_bib48","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.dld.2008.11.020_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000080079","article-title":"Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid dependent moderately severe ulcerative colitis","volume":"70","author":"Hanai","year":"2004","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2008.11.020_bib50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.dld.2008.01.007","article-title":"Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: an unblinded randomised multi-centre controlled study","volume":"40","author":"Hanai","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.11.020_bib51","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/MEG.0b013e3282f5e9f3","article-title":"Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy","volume":"20","author":"Hanai","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.11.020_bib52","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.dld.2008.02.012","article-title":"Adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid na\u00efve patients","volume":"40","author":"Tanaka","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.11.020_bib53","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.dld.2007.04.007","article-title":"Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis","volume":"39","author":"Yamamoto","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.11.020_bib54","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2036.2004.02288.x","article-title":"Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study","volume":"20","author":"Domenech","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.11.020_bib55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.dld.2007.02.003","article-title":"Leukocytapheresis as promising therapy for inflammatory bowel disease","volume":"39","author":"Caprilli","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.11.020_bib56","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.dld.2007.01.010","article-title":"Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients","volume":"39","author":"Takemoto","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.11.020_bib57","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.dld.2007.03.007","article-title":"Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?","volume":"39","author":"Pan\u00e9s","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.11.020_bib58","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/ibd.20505","article-title":"Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse","volume":"14","author":"Maiden","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.11.020_bib59","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.dld.2007.01.001","article-title":"Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study","volume":"39","author":"Bresci","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.11.020_bib60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.gastro.2004.11.024","article-title":"Treating ulcerative colitis without medications\u2014\u201cLook Mom No Drugs!\u201d","volume":"128","author":"Cohen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.11.020_bib61","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.gastro.2008.04.023","article-title":"A randomized, double-blind, sham-controlled study of granulocyte\/monocyte apheresis for active ulcerative colitis","volume":"135","author":"Sands","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.11.020_bib62","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10620-006-9199-9","article-title":"A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis","volume":"51","author":"Suzuki","year":"2006","journal-title":"Dig Dis Sc"},{"key":"10.1016\/j.dld.2008.11.020_bib63","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s10620-005-9050-8","article-title":"Complement activation is involved in biological responses to leukocyte adsorptive apheresis","volume":"51","author":"Nishise","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.11.020_bib64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00011-004-1253-5","article-title":"Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: Evidence for the involvement of plasma IgG, complement C3 and \u03b22 integrin","volume":"53","author":"Takeda","year":"2004","journal-title":"Inflamm Res"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808008591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808008591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:19Z","timestamp":1684886419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865808008591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S1590865808008591"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2008.11.020","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}